Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: SPTX) | Delayed: 20.01 +0.41 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.60 | 52 Week High | $ | |||
| Open | $19.68 | 52 Week Low | $ | |||
| Day High | $21.07 | P/E | N/A | |||
| Day Low | $19.13 | EPS | $ | |||
| Volume | 527,902 | |||||
